Moleculin Biotech Says EMA Grants Orphan Drug Designation To Annamycin To Treat AML

RTTNews | 34 days ago
Moleculin Biotech Says EMA Grants Orphan Drug Designation To Annamycin To Treat AML

(RTTNews) - Pharmaceutical company Moleculin Biotech, Inc. (MBRX) announced Thursday that the European Medicines Agency (EMA) has granted Orphan Drug Designation to Annamycin for the treatment of Acute Myeloid Leukemia (AML).

Annamycin is the Company's next-generation anthracycline that has been designed to be non-cardiotoxic (unlike currently prescribed anthracyclines) and has shown to be non-cardiotoxic in the 82 subjects treated in multiple studies in the U.S. and in Europe.

Annamycin is currently in development for the treatment for AML and STS lung mets, and the Company believes the drug may have the potential to treat additional indications.

Annamycin currently has Fast Track Status and Orphan Drug Designation from the U.S. Food and Drug Administration for the treatment of relapsed or refractory AML, in addition to Orphan Drug Designation for the treatment of STS lung mets.

read more
U.S. Existing Home Sales Unexpectedly Extend Pullback In April

U.S. Existing Home Sales Unexpectedly Extend Pullback In April

Existing home sales in the U.S. unexpectedly saw further downside in the month of April, according to a report released by the National Association of Realtors on Wednesday. NAR said existing home sales slumped by 1.9 percent to an annual rate of 4.14 million in April after tumbling by 3.7 percent to a revised rate of 4.22 million in March.
RTTNews | 5h 38min ago
Hovnanian Enterprises Net Profit Rises 48.9%

Hovnanian Enterprises Net Profit Rises 48.9%

Homebuilder Hovnanian Enterprises Inc. (HOV) reported Wednesday that net income for the second quarter increased 48.9 percent to $50.8 million or $6.66 per share from $34.1 million or $4.47 per share in the prior-year quarter.
RTTNews | 6h 0min ago
Anglo American And BHP Major Shareholder PIC Demands Substantial Revision Of BHP Proposal For Anglo

Anglo American And BHP Major Shareholder PIC Demands Substantial Revision Of BHP Proposal For Anglo

Public Investment Corp. or PIC, a major shareholder of both Anglo American plc (AAUKY.PK, AAL.L) and BHP Group (BHP), on Wednesday said it requires a meaningful revision of the current BHP proposal for Anglo American to "reflect both the embedded value of existing Anglo assets and the future optionality and benefits that BHP can derive, specifically from Anglo's unlisted assets."
RTTNews | 6h 57min ago
Bay Street Likely To Open Lower

Bay Street Likely To Open Lower

Canadian shares are likely to open on a slightly negative note Wednesday morning as energy and materials sectors may find the going somewhat tough due to weak commodity prices.
RTTNews | 7h 46min ago
Biogen To Buy Human Immunology Biosciences In Deal Valued At Up To $1.8 Bln

Biogen To Buy Human Immunology Biosciences In Deal Valued At Up To $1.8 Bln

Biogen Inc. (BIIB) and privately-held biotechnology company Human Immunology Biosciences or HI-Bio, announced Wednesday the companies have entered into a definitive agreement under which Biogen has agreed to acquire HI-Bio for $1.15 billion upfront and up to $650 million in potential milestone payments.
RTTNews | 7h 49min ago
UK Inflation Slows Less Than Expected To 2.3%

UK Inflation Slows Less Than Expected To 2.3%

UK consumer prices rose more than expected in April due to the stickiness of services inflation, which would possibly delay the timing of the first interest rate cut. Consumer prices rose 2.3 percent on a yearly basis in April, slower than the 3.2 percent increase in March, the Office for National Statistics reported Wednesday.
RTTNews | 7h 59min ago